u/sofia_ferreira
Contributes reviews on supplier material. Based in Rosario.
member · joined 15 Jun 2025
Overview — page 3 of 5
comment on dual agonist — my 21-week log, condensed into one table in c/survodutide · 1 points · 7 months ago
glucagon injection is a different vector than GLP-1
comment on rodent data: what the trials say vs what this community says in c/bpc157 · 119 points · 8 months ago
near-zero controlled human data, full stop
comment on nobody warned me about reflux and I would have liked the warning in c/coa · 63 points · 8 months ago
This is the correct framing. The COA structure matters as much as the number.
comment on testing — 12 things I got wrong before I got it right in c/vendorvetting · 4 points · 8 months ago
the reship rate on WXT is actually pretty consistent
comment on the Netherlands: area percent, and what it actually costs here in c/coa · 24 points · 8 months ago
area% is not mass%, and here is exactly why it matters
comment on the Netherlands: area percent, and what it actually costs here in c/coa · 68 points · 8 months ago
The chromatogram trace is where the real information lives. The summary number is just a headline.
comment on external review is the most under-discussed thing in c/glp1muscle in c/insurancefights · 72 points · 8 months ago
I am going to push back on this slightly.
comment on [Meta] proposal — a flair for SURPASS posts in c/trialwatch · 12 points · 10 months ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on switched from 0.5mg to 0.25mg and the nausea got better, not worse in c/vendorvetting · 233 points · 10 months ago
Correct. The batch number is load-bearing information, not optional.
comment on why does nobody talk about SELECT in c/trialwatch · 12 points · 11 months ago
off-label use data is different from approved-indication data
comment on why does nobody talk about VendorInvestigate in c/vendorvetting · 22 points · 11 months ago
receipts or nothing, sorry but that is the rule
comment on [Meta] proposal — a flair for MASH posts in c/survodutide · 15 points · 1 year ago
the heart rate signal is real in the data
comment on small win: TRIUMPH stopped being a problem at week 45 in c/trialwatch · 5 points · 1 year ago
This is correct. Discontinuation arms show the regain reality.
comment on stalled for 17 weeks at 12.5mg and I refuse to panic this time in c/coa · 66 points · 1 year ago
Strongly agree.
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
comment on is it normal to get sulphur burps at week 34 in c/bpc157 · 39 points · 1 year ago
Yeah, rodent data does not scale to humans.
comment on step therapy — my 7-week log, condensed into one table in c/insurancefights · 73 points · 1 year ago
say which country and which plan type
comment on [Results] 96 weeks on 12.5mg, full numbers, ask me anything boring in c/coa · 3 points · 1 year ago
redact your own name, not the vendor's batch details
comment on [Results] 96 weeks on 12.5mg, full numbers, ask me anything boring in c/coa · 149 points · 1 year ago
Strongly agree. Mass% and area% are answering different questions on the same document.
comment on is it normal to get muscle cramps at week 94 in c/insurancefights · 1 points · 1 year ago
step therapy documentation is the weapon, use it
Adding to this: appeal is doing more work than the comment implies.
comment on [Meta] proposal — a flair for survodutide posts in c/survodutide · 46 points · 1 year ago
Strongly agree. The safety story is separate.